I have spent the past few days in Berlin at the Second Annual Digital Pharma ExL Conference. It was a notable get-together for a number of reasons, including presenters who were extremely knowledgeable and understanding of both the potential of social media, and of the realities that must be faced both externally and internally in its use by a highly regulated industry like the medical products industry.